We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration with Isis Pharmaceuticals

News   May 09, 2007

 
Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration with Isis Pharmaceuticals
 
 
 

RELATED ARTICLES

Molecule Could Transform the Treatment of Diabetes

News

Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.

READ MORE

Arming Drug Hunters: Chemists design new reaction for drug discovery

News

The pair of Colorado State University organic chemists have forged a powerful new tool for drug hunters - a simple, elegantly designed chemical reaction that could fling open an underexplored wing of biologically relevant chemistry.

READ MORE

New Inflammation Inhibitor Discovered

News

A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE